The major U.S. index futures are currently pointing to a modestly higher opening on Monday, with stocks likely to move back to the upside following the weakness seen last Friday.
from RTT - Market Analysis https://ift.tt/2n4FBzq
via IFTTT
Cal-Maine Foods, Inc. (CALM) reported Monday a net loss of $45.72 million or $0.94 per share for the first quarter, compared to net income of $12.41 million or $0.26 per share in the year-ago quarter.
from RTT - Earnings https://ift.tt/2oz80hw
via IFTTT
Vasculitis, which refers to inflammation of the blood vessels, is an autoimmune disease wherein the immune system attacks the body's own cells for unknown reasons. There are approximately 20 different disorders that are classified as "vasculitis". (Source: Johns Hopkins Vasculitis Center).
from RTT - Biotech https://ift.tt/2mZ6k0i
via IFTTT
The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 46 listings in the 9-month period of the year and 12 listings in the third quarter.
from RTT - Biotech https://ift.tt/2oj6OPb
via IFTTT
It has been an eventful September, with a number of notable firsts achieved on the regulatory front. Now, let's take a look at the companies that await a ruling from the FDA in October 2019.
from RTT - Biotech https://ift.tt/2miQPQE
via IFTTT
The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to extend the recovery from yesterday's early weakness.
from RTT - Market Analysis https://ift.tt/2m8vj0U
via IFTTT